false2022-06-30Q2--12-310001836056 0001836056 2022-01-01 2022-06-30 0001836056 2022-06-30 0001836056 2021-12-31 0001836056 2021-01-01 2021-06-30 0001836056 2021-01-01 2021-12-31 0001836056 2021-06-30 0001836056 2021-01-01 0001836056 2020-11-30 0001836056 2020-11-01 2020-11-30 0001836056 2005-03-31 0001836056 2021-12-01 2027-11-30 0001836056 2021-04-01 2021-04-30 0001836056 2020-12-31 0001836056 amam:IprAndDMember 2021-12-31 0001836056 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-12-31 0001836056 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001836056 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001836056 amam:ComputersSoftwareAndOfficeEquipmentMember 2021-12-31 0001836056 amam:LaboratoryEquipmentMember 2021-12-31 0001836056 srt:MaximumMember 2021-12-31 0001836056 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2021-12-31 0001836056 amam:MarketableDebtSecuritiesMember 2021-12-31 0001836056 amam:IprAndDMember 2022-06-30 0001836056 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-06-30 0001836056 us-gaap:FurnitureAndFixturesMember 2022-06-30 0001836056 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001836056 amam:ComputersSoftwareAndOfficeEquipmentMember 2022-06-30 0001836056 amam:LaboratoryEquipmentMember 2022-06-30 0001836056 srt:MinimumMember 2022-06-30 0001836056 us-gaap:CommonStockMember 2022-06-30 0001836056 amam:RestatedMemorandumAndArticlesOfAssociationMember 2022-06-30 0001836056 amam:ShangaiAmbrxBiomedicalCompanyLimitedMember 2022-06-30 0001836056 amam:BiolaxyPharmaceuticalHongkongLimitedMember 2022-06-30 0001836056 amam:AmbrxUsMember 2022-06-30 0001836056 amam:AmbrxAustrailiaPtyLimitedMember 2022-06-30 0001836056 dei:AdrMember 2022-06-30 0001836056 amam:LiquidityAndCapitalResourcesMember 2022-06-30 0001836056 amam:ShanghaiAmbrxBiomedicalCoLtdMember 2022-06-30 0001836056 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001836056 us-gaap:CertificatesOfDepositMember amam:MarketableDebtSecuritiesAvailableForSaleMaturityDueGreaterThan90DaysAndLessThanOneYearMember 2022-06-30 0001836056 us-gaap:CommercialPaperMember amam:MarketableDebtSecuritiesAvailableForSaleMaturityDueGreaterThan90DaysAndLessThanOneYearMember 2022-06-30 0001836056 us-gaap:CorporateDebtSecuritiesMember amam:MarketableDebtSecuritiesAvailableForSaleMaturityDueGreaterThan90DaysAndLessThanOneYearMember 2022-06-30 0001836056 us-gaap:USGovernmentDebtSecuritiesMember amam:MarketableDebtSecuritiesAvailableForSaleMaturityDueGreaterThan90DaysAndLessThanOneYearMember 2022-06-30 0001836056 amam:MarketableDebtSecuritiesAvailableForSaleMaturityDueGreaterThan90DaysAndLessThanOneYearMember 2022-06-30 0001836056 us-gaap:AssetBackedSecuritiesMember amam:MarketableDebtSecuritiesAvailableForSaleMatuirtyDueOneToThreeYearsMember 2022-06-30 0001836056 us-gaap:CorporateDebtSecuritiesMember amam:MarketableDebtSecuritiesAvailableForSaleMatuirtyDueOneToThreeYearsMember 2022-06-30 0001836056 amam:NonUsGovernmentSecuritiesMember amam:MarketableDebtSecuritiesAvailableForSaleMatuirtyDueOneToThreeYearsMember 2022-06-30 0001836056 us-gaap:USGovernmentDebtSecuritiesMember amam:MarketableDebtSecuritiesAvailableForSaleMatuirtyDueOneToThreeYearsMember 2022-06-30 0001836056 amam:MarketableDebtSecuritiesAvailableForSaleMatuirtyDueOneToThreeYearsMember 2022-06-30 0001836056 amam:MarketableDebtSecuritiesMember 2022-06-30 0001836056 us-gaap:CashAndCashEquivalentsMember 2022-06-30 0001836056 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CertificatesOfDepositMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 amam:NonUsGovernmentSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 amam:NonUsGovernmentSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 amam:NonUsGovernmentSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 amam:NonUsGovernmentSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001836056 amam:SeriesBConvertiblePreferredStockMember 2021-01-01 2021-06-30 0001836056 amam:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-06-30 0001836056 amam:RedeemableNoncontrollingInterestsMember 2021-01-01 2021-06-30 0001836056 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001836056 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember amam:FirstCustomerFromTopThreeCustomerMember 2021-01-01 2021-06-30 0001836056 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember amam:SecondCustomerFromTopThreeCustomerMember 2021-01-01 2021-06-30 0001836056 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember amam:ThirdCustomerFromTopThreeCustomerMember 2021-01-01 2021-06-30 0001836056 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001836056 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001836056 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0001836056 amam:LicenseFeesMember 2021-01-01 2021-06-30 0001836056 amam:ReimbursementsMember 2021-01-01 2021-06-30 0001836056 amam:ResearchAndDevelopmentServicesMember 2021-01-01 2021-06-30 0001836056 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001836056 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-06-30 0001836056 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001836056 us-gaap:TechnologyBasedIntangibleAssetsMember us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001836056 us-gaap:InProcessResearchAndDevelopmentMember 2021-01-01 2021-06-30 0001836056 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-06-30 0001836056 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001836056 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember amam:FirstCustomerFromTopThreeCustomerMember 2022-01-01 2022-06-30 0001836056 amam:FirstCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2022-01-01 2022-06-30 0001836056 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember amam:SecondCustomerMember 2022-01-01 2022-06-30 0001836056 amam:TemporaryEquityMember us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-06-30 0001836056 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001836056 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001836056 amam:LicenseFeesMember 2022-01-01 2022-06-30 0001836056 amam:ReimbursementsMember 2022-01-01 2022-06-30 0001836056 amam:ResearchAndDevelopmentServicesMember 2022-01-01 2022-06-30 0001836056 amam:LicenseFeesMember 2022-01-01 2022-06-30 0001836056 amam:ReimbursementsMember 2022-01-01 2022-06-30 0001836056 amam:DevelopmentAndCommercializationAgreementMember amam:SinoBiopharmaceuticalLimitedMember 2022-01-01 2022-06-30 0001836056 us-gaap:EmployeeStockOptionMember amam:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-01-01 2022-06-30 0001836056 amam:TwoThousandAndTwentyOnePlanMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001836056 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001836056 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-06-30 0001836056 dei:AdrMember 2022-01-01 2022-06-30 0001836056 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001836056 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001836056 amam:ShangaiAmbrxBiomedicalCompanyLimitedMember 2022-01-01 2022-06-30 0001836056 us-gaap:IPOMember 2022-01-01 2022-06-30 0001836056 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-06-30 0001836056 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-06-30 0001836056 us-gaap:TechnologyBasedIntangibleAssetsMember amam:BmsRelaxInAgreementMember 2022-01-01 2022-06-30 0001836056 amam:SeriesBConvertiblePreferredStockMember 2022-01-01 2022-06-30 0001836056 amam:MarketableDebtSecuritiesMember 2022-01-01 2022-06-30 0001836056 us-gaap:InProcessResearchAndDevelopmentMember 2022-01-01 2022-06-30 0001836056 amam:ShangaiAmbrxBiomedicalCompanyLimitedMember 2021-04-01 2021-04-30 0001836056 amam:ShangaiAmbrxBiomedicalCompanyLimitedMember 2022-01-01 2022-03-31 0001836056 amam:BmsRelaxInAgreementMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-03-31 0001836056 amam:ShanghaiAmbrxBiomedicalCoLtdMember 2021-04-30 0001836056 amam:ShangaiAmbrxBiomedicalCompanyLimitedMember 2021-03-31 0001836056 us-gaap:OverAllotmentOptionMember 2021-07-01 2021-07-31 0001836056 us-gaap:OverAllotmentOptionMember 2021-07-31 0001836056 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-12-31 0001836056 amam:FirstCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2021-01-01 2021-12-31 0001836056 amam:SecondCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2021-01-01 2021-12-31 0001836056 amam:LicenseFeesMember 2021-01-01 2021-12-31 0001836056 amam:ReimbursementsMember 2021-01-01 2021-12-31 0001836056 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-12-31 0001836056 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-12-31 0001836056 us-gaap:TechnologyBasedIntangibleAssetsMember us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001836056 srt:MaximumMember 2020-11-01 2020-11-30 0001836056 srt:MinimumMember 2020-11-01 2020-11-30 0001836056 amam:SeriesBRedeemableConvertiblePreferredStockMember us-gaap:IPOMember 2020-11-01 2020-11-30 0001836056 amam:SeriesAAndSeriesBRedeemableConvertiblePreferredStockMember us-gaap:IPOMember 2020-11-01 2020-11-30 0001836056 amam:SeriesBRedeemableConvertiblePreferredStockMember us-gaap:IPOMember 2020-11-30 0001836056 amam:IntellectualPropertyLicensesMember amam:LonzaSalesAgMember 2019-12-11 2019-12-11 0001836056 srt:MaximumMember amam:IntellectualPropertyLicensesMember amam:LonzaSalesAgMember 2019-12-11 2019-12-11 0001836056 amam:BeiGeneLimitedMember 2019-03-01 2019-03-31 0001836056 srt:MaximumMember amam:BeiGeneLimitedMember amam:CollaborationAndExclusiveLicenseAgreementMember 2019-03-01 2019-03-31 0001836056 srt:MinimumMember amam:BeiGeneLimitedMember amam:CollaborationAndExclusiveLicenseAgreementMember 2019-03-01 2019-03-31 0001836056 amam:DevelopmentAndCommercializationAgreementMember amam:SinoBiopharmaceuticalLimitedMember 2020-01-01 2020-01-31 0001836056 amam:DevelopmentAndCommercializationAgreementMember amam:SinoBiopharmaceuticalLimitedMember amam:PhaseOneClinicalTrialForProductsArxEightTwentyTwoAndArxOneHundredAndTwoMember 2020-12-31 0001836056 amam:NovocodexMember amam:DevelopmentAndCommercializationAgreementMember 2019-10-01 2019-10-31 0001836056 srt:MinimumMember amam:NovocodexMember amam:DevelopmentAndCommercializationAgreementMember 2019-10-01 2019-10-31 0001836056 amam:BmsRelaxInAgreementMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-04-01 2022-06-30 0001836056 amam:MarketableDebtSecuritiesMember 2022-06-30 2022-06-30 0001836056 amam:RedeemableNoncontrollingInterestsMember 2020-12-31 0001836056 amam:SeriesAConvertiblePreferredStockMember 2020-12-31 0001836056 amam:SeriesBConvertiblePreferredStockMember 2020-12-31 0001836056 amam:SeriesBConvertiblePreferredStockMember 2021-06-30 0001836056 amam:SeriesAConvertiblePreferredStockMember 2021-06-30 0001836056 us-gaap:RetainedEarningsMember 2020-12-31 0001836056 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001836056 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001836056 us-gaap:CommonStockMember 2020-12-31 0001836056 us-gaap:CommonStockMember 2021-06-30 0001836056 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001836056 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001836056 us-gaap:RetainedEarningsMember 2021-06-30 0001836056 us-gaap:RetainedEarningsMember 2021-12-31 0001836056 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001836056 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001836056 us-gaap:CommonStockMember 2021-12-31 0001836056 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001836056 us-gaap:RetainedEarningsMember 2022-06-30 iso4217:USD xbrli:shares utr:Year xbrli:pure utr:Month iso4217:CHF utr:sqft iso4217:USD xbrli:shares amam:FullTimeEquivalentServices amam:FTE amam:Patients
Table of Contents
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
6-K
 
 
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
August 2
9
, 2022
(Commission File
No. 001-40505)
 
 
Ambrx Biopharma Inc.
(Translation of registrant’s name into English)
 
 
Cayman Islands
(Jurisdiction of incorporation or organization)
10975 Torrey Pines Road
La Jolla, California 92037
(Address of registrant’s principal executive office)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form
20-F
or Form
40-F.
Form
20-F  ☒            Form
40-F  ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(1):  ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7):  ☐
 
 
 
Table of Contents
Financial Statements for the Six Months Ended June 30, 2022
Ambrx Biopharma Inc. (the “Company”) is furnishing this report on Form
6-K
to provide its unaudited condensed consolidated financial statements for the six months ended June 30, 2022 and 2021.
The unaudited condensed consolidated financial statements as of June 30, 2022 and for the six months ended June 30, 2022 and 2021 are attached to this Form
6-K
as Exhibit 99.1.
This report on Form
6-K
is hereby incorporated by reference into the Company’s Registration Statements on Form
S-8
(Registration
No. 333-257264
and
No. 333-264490)
and Form
F-3
(Registration
No. 333-266404).
Exhibits
 
Exhibit
Number
  
Exhibit Description
99.1
  
101.INS
  
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.CAL
  
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH
  
Inline XBRL Taxonomy Extension Schema Document
101.DEF
  
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
  
Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE
  
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
  
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
 
Ambrx Biopharma Inc.
By:
 
/s/ Kate Hermans
Name:
 
Kate Hermans
Title:
 
Interim Chief Executive Officer and President
Date: August 2
9
, 2022